Glioblastoma is an aggressive type of brain cancer that affects astrocytes, a type of cells in the brain that supports neurons. It is difficult to treat, and a cure is often not possible. Treatments are aimed at slowing the progression of cancer. Phase 1 clinical trial results show that a common cold virus engineered to attack brain tumors increased the survival rate in twenty percent of recurrent glioblastoma patients. The engineered virus, Delta-24-RGD, added an extra three years or more to the overall survival time in these patients.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer